DJIA 18,132.70 -81.72 -0.45%
NASDAQ 4,963.53 -24.36 -0.49%
S&P 500 2,104.50 -6.24 -0.30%
market minute promo

413.84 -6.03 (-1.44%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

REGN $413.84 -1.44%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $421.04
Previous Close $419.87
Daily Range $411.04 - $421.07
52-Week Range $269.50 - $437.64
Market Cap $42.5B
P/E Ratio 136.77
Dividend (Yield) $0.00 (0.0%)
Volume 811,005
Average Daily Volume 813,671
Current FY EPS $7.79

Sector

Healthcare

Industry

Drug Makers

Regeneron Pharmaceuticals, Inc. (REGN) Description

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions. Website: http://www.regeneron.com/

News & Commentary

Billions on the Line in the Next Drug Pricing War

Could approval of two new cholesterol drugs lead to another high stakes pricing war?

Biotech Stock Roundup: Pharmacyclics Up on Buyout Rumors, Celgene Drug Label Expanded - Analyst B

Biotech Stock Roundup: Pharmacyclics Up on Buyout Rumors, Celgene Drug Label Expanded - Analyst Blog

Can These Three BioTech Companies Make It Big?

Comparing America's Next 3 Biotechnology Companies

Regeneron's Eylea Tops Diabetic Macular Edema Study - Analyst Blog

Thursday's ETF Movers: PBE, ICF

Nasdaq 100 Movers: VIP, PCLN

Regeneron Beats on Q4 Earnings Driven by Eylea Sales (revised) - Analyst Blog

Stock Market News for February 18, 2015 - Market News

'Mad Money' Lightning Round: Buy, Buy, Buy Terrific Lowe's

See More REGN News...

REGN's Top Competitors

REGN $413.84 (-1.44%)
Current stock: REGN
GILD $103.53 (-0.63%)
Current stock: GILD
CELG $121.53 (-1.48%)
Current stock: CELG
BIIB $409.59 (-0.12%)
Current stock: BIIB